Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury (Q38256778)

1 September 2017

1 reference

title

Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury (English)

1 reference

1 September 2017

0 references

1 reference

1 reference

Nattayaporn Apaijai

1 reference

1 September 2017

Siriporn C Chattipakorn

series ordinal

1 reference

1 September 2017

Nipon Chattipakorn

series ordinal

1 reference

1 September 2017

publication date

1 December 2014

1 reference

Cardiovascular Drugs and Therapy

1 September 2017

published in

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

1 September 2017

page(s)

549-562

1 reference

Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone.

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Neuropeptide Y in normal eating and in genetic and dietary-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Foxc2 is a common mediator of insulin and transforming growth factor beta signaling to regulate plasminogen activator inhibitor type I gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

High-fat, low-carbohydrate diet alters myocardial oxidative stress and impairs recovery of cardiac function after ischemia and reperfusion in obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Isolated heart function during ischemia and reperfusion in sucrose-fed rats: effect of insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Effects of insulin resistance on geranylgeranylacetone-induced expression of heat shock protein 72 and cardioprotection in high-fat diet rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Fructose-Fed Rats Are Protected against Ischemia/Reperfusion Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Variations in mortality by weight among 750,000 men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Myocardial reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Metabolic flexibility and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Fatty acid metabolism is enhanced in type 2 diabetic hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Low-pressure reperfusion alters mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Permeability of rat heart myocytes to cytochrome c.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

AMPK: a nutrient and energy sensor that maintains energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Heat-shock protein 70 antagonizes apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Body mass index and incident hospitalisation for cardiovascular disease in 158 546 participants from the 45 and Up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Obesity paradox and risk of sudden death in heart failure results from the MUerte Subita en Insuficiencia cardiaca (MUSIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of obesity on long-term prognosis following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

The obesity paradox and myocardial infarct size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Obesity paradox in patients with hypertension and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

The relationship between obesity and mortality in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6553-6

10.1007/S10557-014-6553-6

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference